Related Experiment Video

Updated: Jun 21, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

When hypertension and diabetes coexist: strategies for cardiorenal protection

M A Weber1

  • 1State University of New York Downstate College of Medicine, New York, USA.

Postgraduate Medicine
|August 12, 2009
PubMed

Insights

Managing diabetes and hypertension together is crucial. Effective antihypertensive therapy, especially with ACE inhibitors, significantly reduces cardiovascular and renal risks, particularly in diabetic patients.

Area of Science:

  • Cardiology
  • Nephrology
  • Endocrinology

Background:

  • Diabetes and hypertension often coexist, exacerbating cardiovascular and renal risks.
  • Combined conditions increase morbidity and mortality compared to either alone.

Purpose of the Study:

  • To evaluate the benefits of antihypertensive therapy in patients with coexisting diabetes and hypertension.
  • To highlight the cardiorenal protective effects of specific drug classes.

Main Methods:

  • Review of studies on antihypertensive drug therapy in diabetic and non-diabetic patients.
  • Analysis of cardiorenal outcomes associated with angiotensin-converting enzyme inhibitors (ACEIs) and calcium channel blockers (CCBs).

Main Results:

  • Antihypertensive therapy benefits both diabetic and non-diabetic individuals.
  • Greatest risk reduction observed in patients with diabetes.
  • ACEIs, alone or with CCBs, demonstrate cardiorenal protective effects.

Conclusions:

  • Screening hypertensive patients for diabetes is essential.
  • Aggressive hypertension control is vital for patients with diabetes.
  • Combined ACEI and CCB therapy may offer significant cardiorenal protection.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...